← Open Payments lookup

MARTIN STOLTENBERG: Open Payments

NPI 1730303157 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,252 in 91 payments from 13 companies in 2025. Trend: 2023 $1,145 · 2024 $1,260 · 2025 $2,252

Food & beverage: $2,249Education: $4
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)22$673
Vanda Pharmaceuticals Inc.18$410
Axsome Therapeutics, Inc.9$373
ABBVIE INC.19$371
Supernus Pharmaceuticals, Inc.7$173
Otsuka America Pharmaceutical, Inc.3$54
E.R. Squibb & Sons, L.L.C.3$53
Noven Therapeutics, LLC3$43
Lundbeck LLC2$30
Takeda Pharmaceuticals U.S.A., Inc.2$28

Products named: CAPLYTA, Auvelity, VRAYLAR, FANAPT, Qelbree, HETLIOZ, REXULTI, COBENFY.

Industry payments across NE — which companies pay providers there.